A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent. Ikris Pharma International is authorized to distribute and export pharmaceutical drugs worldwide. Our large business volume provides us the greater strength to negotiate with major manufacturers, distributors and suppliers to get better prices compared to other competitors. We pass this benefit to our valued customers. We are working with many of the US, India, China, Europe, Middle East, Canada and UK generic and clinical research based companies and supply the Reference Listed Drugs (RLD) / Innovator products at competitive prices.